GapMinder Fund II has invested €1 million in the Romanian startup Parol, which utilizes AI to automate medical record generation, enhancing efficiency in healthcare documentation.

Target Information

Parol is an innovative Romanian startup founded in 2022 by a team of journalists, namely Claudiu Pândaru (CEO), Alex Livadaru (COO), along with Alex Tepeș (CTO), a software solutions developer, and Valentin Ichim (Sales Manager), who brings over ten years of sales experience. The company has developed an AI-powered platform that significantly transforms healthcare documentation management by automating the generation of medical records through real-time transcription of doctor-patient conversations.

Parol's solution enables healthcare professionals to spend less time on bureaucratic tasks by generating complete and accurate medical records in mere seconds. With its technology integrated into existing clinical workflows, Parol effectively minimizes disruptions while enhancing efficiency, making it a key player in the medical technology sector.

Industry Overview

The healthcare industry in Romania is increasingly embracing digital solutions and technological advancements, showing promising growth potential. As healthcare systems worldwide face pressures to improve efficiency and reduce costs, Romania is

View Source

Similar Deals

Catalyst Romania .lumen

2025

Seed Stage Glasses, Spectacles & Contact Lenses Romania
Elaia, Pfizer Ventures, Bpifrance Enodia Therapeutics

2026

Seed Stage Bio Therapeutic Drugs France
Cardumen Capital Biographica

2026

Seed Stage Biotechnology & Medical Research (NEC) United Kingdom
Lifespan Vision Ventures TECregen

2026

Seed Stage Bio Therapeutic Drugs Switzerland
Rethink VC Avela Health

2026

Seed Stage Telemedicine Services United States of America

GapMinder Fund II

invested in

Parol

in 2024

in a Seed Stage deal

Disclosed details

Transaction Size: $1M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert